Results 131 to 140 of about 15,099 (182)

A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative Workshop. [PDF]

Kidney Int Rep
Oni L, Smith R, Ozen S, Williams C, Davies E, King C, Brogan P, Haas M, Barratt J, Hafkin J, Eleftheriou D, Keat K, Smith E, Ding W, Cheung C, Platt C, Pillebout E, Chetwynd A, Alladin A, Vaglio A, Jones C, Pain C, Sunderkötter C, Peipert J, Barnes E, Trivioli G, Hardwick H, Morgan H, Bajema I, Wason J, Wade J, Sanchez-Manubens J, Vernon K, Willcocks L, Harper L, Lindsay L, Beldie MA, Marlais M, O'Shaughnessy M, Gkargkoula P, Hamilton P, Bakry R, Bogos R, Demir S, Brix S, Appenzeller S, Bansal T, Anastasa Z, Marks SD, Audemard-Verger A, Renson T, Jelusic M, Jayne D, Salama A.   +53 more
europepmc   +1 more source

The health-related quality of life in children with IgA vasculitis. [PDF]

Front Pediatr
Zhou J, Nie M, Song Z, Shen X.
europepmc   +1 more source

Study on the correlation between atmospheric pollutants and the development of IgA vasculitis. [PDF]

Medicine (Baltimore)
Pu F, Hao YQ.
europepmc   +1 more source

Exhausted natural killer cells in adult IgA vasculitis. [PDF]

Arthritis Res Ther
Bajželj M, Senjor E, Boštic N, Hladnik M, Sodin-Šemrl S, Perišić Nanut M, Kos J, Ihan A, Hočevar A, Kopitar AN, Lakota K.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

IgA vasculitis nephritis

Current Opinion in Pediatrics, 2022
Purpose of review The purpose of this update is to summarize current knowledge on the pathophysiology of immunglobulin A (IgA) vasculitis nephritis (IgAVN) as well as to critically review evidence for established therapeutic regimes and available biomarkers. An additional purpose is to raise the discussion what could be done to
Eva, Nüsken, Lutz T, Weber
openaire   +2 more sources

Geospatial clustering of childhood IgA vasculitis and IgA vasculitis-associated nephritis

Annals of the Rheumatic Diseases, 2021
Research on spatial variability of the incidence of IgA vasculitis (IgAV) in children and its potential implications for elucidation of the multifactorial aetiology and pathogenesis is limited. We intended to observe spatial variability of the incidence of IgAV and IgA vasculitis-associated nephritis (IgAVN) using modern geostatistical methods, and ...
Matej Sapina, Marijan Frkovic, Mario Sestan, Sasa Srsen, Aleksandar Ovuka, Mateja Batnozic Varga, Karolina Kramaric, Dario Brdaric, Kresimir Milas, Alenka Gagro, Marija Jelusic   +10 more
openaire   +3 more sources

Management of IgA Vasculitis with Nephritis

Pediatric Drugs, 2021
Immunoglobulin A (IgA) vasculitis (IgAV), previously called Henoch-Schönlein purpura, is characterized by IgA-dominant immune deposits affecting small vessels and often involves the skin, gastrointestinal tract, joints, and kidneys. IgAV is the most common cause of systemic vasculitis in children.
Jean-Daniel, Delbet, Cyrielle, Parmentier, Claire, Herbez Rea, Antoine, Mouche, Tim, Ulinski   +4 more
openaire   +2 more sources

IgA vasculitis induced by acenocoumarol

Reumatología Clínica (English Edition), 2020
We present the case of a 73-year-old man with IgA vasculitis after administration of acenocoumarol, confirmed by anatomopathological study. He had cutaneous, joint and renal involvement. With the reintroduction of the drug, the clinical manifestations worsened. They were completely resolved with its suspension, without additional maintenance treatment.
Sara, Esteban Terradillos, José Gabriel, Erdozain Castiella, Juan Manuel, Goiri Aparicio, Juan Antonio, Ratón Nieto, Aitor, Fernández Larrinoa Santamaria, Juan, Monte Armenteros   +5 more
openaire   +2 more sources